Description:
68Ga-PSMA-CYC is a novel radiotracer targeting PSMA. In this study, we investigated the safety, biodistribution, radiation dosimetry of 68Ga-PSMA-CYC PET/CT in patients with prostate cancer, and performed a head-to-head comparison with 68Ga-PSMA-617 and 68Ga-PSMA-11 to evaluate its diagnostic performance.
Sponsor:
First Affiliated Hospital of Fujian Medical University
Contacts:
Weibing Miao, MDmiaoweibing@126.com
059187981618
Jie Zang, MD15901495106@163.com
15901495106
Government Study Link:
NCT07056790 - Click here to see study onClinicalTrials.gov